ICUIICU Medical, Inc.

$3B

Q4 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$320M+1.6% YoY

Gross Profit

$120M37.4% margin

Operating Income

$27M8.4% margin

Net Income

$26M8.2% margin

EPS (Diluted)

$1.21

QoQ Revenue Growth

+0.6%

Cash Flow

Operating Cash Flow

$79M

Free Cash Flow

$47M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$261M

Stockholders' Equity

$1.5B

Cash & Equivalents

$396M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$320M	$316M	+1.6%
Gross Profit	$120M	$114M	+5.0%
Operating Income	$27M	$18M	+51.6%
Net Income	$26M	$21M	+26.7%

Revenue Segments

Infusion Consumables

$123M38%

IV Solutions

$94M29%

Infusion Systems

$92M29%

Critical Care

$12M4%

Geographic Segments

UNITED STATES

$235M73%

Other foreign countries

$52M16%

EMEA

$34M11%

ICUI Q4 2020 Earnings — ICU Medical, Inc. Revenue & Financial Results | Market Cap Arena